Restless Legs Syndrome/Willis Ekbom Disease (eBook, PDF)
Long-Term Consequences and Management
Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
Restless Legs Syndrome/Willis Ekbom Disease (eBook, PDF)
Long-Term Consequences and Management
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
![](https://bilder.buecher.de/images/aktion/tolino/tolino-select-logo.png)
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
![](https://bilder.buecher.de/images/aktion/tolino/tolino-select-logo.png)
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Due to the fact that Restless Legs Syndrome/Willis-Ekbom Disease is usually a chronic condition, this book aims to provide physicians with the necessary tools for the long-term management of patients with RLS. The first part of the book addresses the various comorbidities and long-term consequences of RLS on life quality, sleep, cognitive, psychiatric and cardiovascular systems, while the second part focuses on the management of long-term treatment and the drug-induced complications in primary RLS and in special populations. Written by experts in the field, this practical resource offers a…mehr
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 4.31MB
- Upload möglich
Due to the fact that Restless Legs Syndrome/Willis-Ekbom Disease is usually a chronic condition, this book aims to provide physicians with the necessary tools for the long-term management of patients with RLS. The first part of the book addresses the various comorbidities and long-term consequences of RLS on life quality, sleep, cognitive, psychiatric and cardiovascular systems, while the second part focuses on the management of long-term treatment and the drug-induced complications in primary RLS and in special populations. Written by experts in the field, this practical resource offers a high-quality, long-term management of RLS for neurologists, sleep clinicians, pulmonologists and other healthcare professionals.
Produktdetails
- Produktdetails
- Verlag: Springer New York
- Erscheinungstermin: 7. Mai 2017
- Englisch
- ISBN-13: 9781493967773
- Artikelnr.: 53031668
- Verlag: Springer New York
- Erscheinungstermin: 7. Mai 2017
- Englisch
- ISBN-13: 9781493967773
- Artikelnr.: 53031668
Mauro Manconi, MD, PhD Sleep and Epilepsy Center Neurocenter of Southern Switzerland Civic Hospital Lugano, Switzerland
Diego García-Borreguero, MD, PhD Sleep Research Institute Madrid, Spain
Diego García-Borreguero, MD, PhD Sleep Research Institute Madrid, Spain
I. Long Term Health Consequences of Restless Legs Syndrome/Willis-Ekbom Disease.- 1. Mental Health Disorders Associated with RLS.- 2. Sleep Impact: Insomnia, Hypersomnia, Sleep Attacks, and Circadian Disorders.- 3. Cognitive Functioning.- 4. Health Related Quality of Life and Depression/Anxiety Symptom Measures for the Assessment of Treatment in Restless Legs Syndrome/Willis-Ekbom Disease.- 5. Epidemiologic Evidence in Cardiovascular Disease.- 6. Heart Rate and Blood Pressure Changes Associated with Periodic Limb Movements.- 7. Willis-Ekbom Disease, Periodic Limb Movements of Sleep, and Cardiovascular Disease: Putative Mechanisms and Implications for Long-Term Treatment.- 8. Peripheral Muscle Changes.- 9. Outcome and Mortality in Renal Failure-Related RLS.- II. Long Term Management of Restless Legs Syndrome/Willis-Ekbom Disease.- 10. Long Term Pharmacological Treatment.- 11. Augmentation: Criteria, Prevalence, and DifferentialDiagnosis.- 12. Treatment Options When Short-Acting Dopamine Agonists Fail or Cause Augmentation: Switching or Adding Medications.- 13. Management of Augmentation.- 14. Managing Concurrent Medications.- 15. Impulsive Behaviors: Definition, Prevalence, Neurobiology, and Management.- 16. Impulse Control Behavior in Movement Disorders: Focus on Restless Leg Syndrome.- 17. Management of RLS During Pregnancy.- 18. Management of RLS in Children (Unique Features).
I. Long Term Health Consequences of Restless Legs Syndrome/Willis-Ekbom Disease.- 1. Mental Health Disorders Associated with RLS.- 2. Sleep Impact: Insomnia, Hypersomnia, Sleep Attacks, and Circadian Disorders.- 3. Cognitive Functioning.- 4. Health Related Quality of Life and Depression/Anxiety Symptom Measures for the Assessment of Treatment in Restless Legs Syndrome/Willis-Ekbom Disease.- 5. Epidemiologic Evidence in Cardiovascular Disease.- 6. Heart Rate and Blood Pressure Changes Associated with Periodic Limb Movements.- 7. Willis-Ekbom Disease, Periodic Limb Movements of Sleep, and Cardiovascular Disease: Putative Mechanisms and Implications for Long-Term Treatment.- 8. Peripheral Muscle Changes.- 9. Outcome and Mortality in Renal Failure-Related RLS.- II. Long Term Management of Restless Legs Syndrome/Willis-Ekbom Disease.- 10. Long Term Pharmacological Treatment.- 11. Augmentation: Criteria, Prevalence, and DifferentialDiagnosis.- 12. Treatment Options When Short-Acting Dopamine Agonists Fail or Cause Augmentation: Switching or Adding Medications.- 13. Management of Augmentation.- 14. Managing Concurrent Medications.- 15. Impulsive Behaviors: Definition, Prevalence, Neurobiology, and Management.- 16. Impulse Control Behavior in Movement Disorders: Focus on Restless Leg Syndrome.- 17. Management of RLS During Pregnancy.- 18. Management of RLS in Children (Unique Features).
I. Long Term Health Consequences of Restless Legs Syndrome/Willis-Ekbom Disease.- 1. Mental Health Disorders Associated with RLS.- 2. Sleep Impact: Insomnia, Hypersomnia, Sleep Attacks, and Circadian Disorders.- 3. Cognitive Functioning.- 4. Health Related Quality of Life and Depression/Anxiety Symptom Measures for the Assessment of Treatment in Restless Legs Syndrome/Willis-Ekbom Disease.- 5. Epidemiologic Evidence in Cardiovascular Disease.- 6. Heart Rate and Blood Pressure Changes Associated with Periodic Limb Movements.- 7. Willis-Ekbom Disease, Periodic Limb Movements of Sleep, and Cardiovascular Disease: Putative Mechanisms and Implications for Long-Term Treatment.- 8. Peripheral Muscle Changes.- 9. Outcome and Mortality in Renal Failure-Related RLS.- II. Long Term Management of Restless Legs Syndrome/Willis-Ekbom Disease.- 10. Long Term Pharmacological Treatment.- 11. Augmentation: Criteria, Prevalence, and DifferentialDiagnosis.- 12. Treatment Options When Short-Acting Dopamine Agonists Fail or Cause Augmentation: Switching or Adding Medications.- 13. Management of Augmentation.- 14. Managing Concurrent Medications.- 15. Impulsive Behaviors: Definition, Prevalence, Neurobiology, and Management.- 16. Impulse Control Behavior in Movement Disorders: Focus on Restless Leg Syndrome.- 17. Management of RLS During Pregnancy.- 18. Management of RLS in Children (Unique Features).
I. Long Term Health Consequences of Restless Legs Syndrome/Willis-Ekbom Disease.- 1. Mental Health Disorders Associated with RLS.- 2. Sleep Impact: Insomnia, Hypersomnia, Sleep Attacks, and Circadian Disorders.- 3. Cognitive Functioning.- 4. Health Related Quality of Life and Depression/Anxiety Symptom Measures for the Assessment of Treatment in Restless Legs Syndrome/Willis-Ekbom Disease.- 5. Epidemiologic Evidence in Cardiovascular Disease.- 6. Heart Rate and Blood Pressure Changes Associated with Periodic Limb Movements.- 7. Willis-Ekbom Disease, Periodic Limb Movements of Sleep, and Cardiovascular Disease: Putative Mechanisms and Implications for Long-Term Treatment.- 8. Peripheral Muscle Changes.- 9. Outcome and Mortality in Renal Failure-Related RLS.- II. Long Term Management of Restless Legs Syndrome/Willis-Ekbom Disease.- 10. Long Term Pharmacological Treatment.- 11. Augmentation: Criteria, Prevalence, and DifferentialDiagnosis.- 12. Treatment Options When Short-Acting Dopamine Agonists Fail or Cause Augmentation: Switching or Adding Medications.- 13. Management of Augmentation.- 14. Managing Concurrent Medications.- 15. Impulsive Behaviors: Definition, Prevalence, Neurobiology, and Management.- 16. Impulse Control Behavior in Movement Disorders: Focus on Restless Leg Syndrome.- 17. Management of RLS During Pregnancy.- 18. Management of RLS in Children (Unique Features).